14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.25 $2.84 Wednesday, 17th Aug 2022 HTBX stock ended at $2.38. During the day the stock fluctuated 0% from a day low at $2.38 to a day high of $2.38.
90 days $1.94 $3.15
52 weeks $1.94 $7.63

Historical Heat Biologics prices

Date Open High Low Close Volume
Jan 29, 2016 $27.30 $31.20 $24.30 $24.50 5 940
Jan 28, 2016 $27.80 $27.80 $24.60 $26.70 990
Jan 27, 2016 $26.70 $27.90 $24.00 $26.00 2 380
Jan 26, 2016 $26.20 $28.00 $23.90 $26.10 3 740
Jan 25, 2016 $24.40 $26.40 $21.50 $23.90 2 510
Jan 22, 2016 $21.80 $26.50 $20.00 $25.70 15 160
Jan 21, 2016 $21.30 $24.30 $21.10 $22.60 1 850
Jan 20, 2016 $22.00 $22.00 $20.10 $21.40 3 740
Jan 19, 2016 $24.80 $24.80 $22.10 $22.20 3 810
Jan 15, 2016 $24.80 $26.20 $24.50 $25.10 3 240
Jan 14, 2016 $24.30 $26.10 $23.50 $24.70 3 230
Jan 13, 2016 $23.50 $26.50 $23.50 $24.30 7 960
Jan 12, 2016 $23.40 $25.00 $22.70 $23.50 2 090
Jan 11, 2016 $28.00 $28.60 $24.00 $24.70 8 990
Jan 08, 2016 $30.80 $36.10 $28.90 $28.90 15 310
Jan 07, 2016 $41.90 $42.80 $29.20 $31.10 31 920
Jan 06, 2016 $38.80 $47.10 $33.40 $43.20 129 420
Jan 05, 2016 $25.90 $39.30 $24.70 $36.60 59 460
Click to get the best stock tips daily for free!

About Heat Biologics

Heat Biologics Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against sp... HTBX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT